Yokogawa Industry Blog

chemical and pharmaceutical

The Future of High Content Analysis is 3D

Yokogawa and InSphero combine the power of advanced HCA (High Content Analysis) platform with multicellular 3D models for drug discovery.

Read More

EuroPACT in Copenhagen: EU-wide PAT Trialogue

For several years Werner Worringen has been working as Industry Marketing Manager Analytical Solutions at Yokogawa Germany. Since then he has also been involved in numerous committees relating to process analytics. As a member of the extended executive board, he is also a member of the Process Analytics Working Group (AK PAT), which was established in 2005 and now has 365 members. Working group of the Division of Analytical Chemistry within the German Chemical Society (GDCh), which works closely with DECHEMA (Society for Chemical Engineering and Biotechnology). This is also the case with regard to EuroPACT, which will be held in Copenhagen in May.

Read More

The most popular blog articles of 2019

To start 2020, we look back to 2019 on the Chemicals and Pharmaceuticals blog and present the ten most read articles of the past year in an exciting and worthwhile top ten list.

Read More

AR and VR offer enormous potential – including for the process industry

#BLOG Augmented Reality and Virtual Reality – even if their exact meaning is certainly not familiar to everyone, today at least everyone should have heard of these two terms before. And this mostly in connection with video games like #Pokémon Go, #TV and movies. Or perhaps with a view to architecture, sports, medicine, navigation, (flight and driving) simulation, learning, art, photography, or entertainment in general.
But both augmented and virtual reality have long since found their way into the (process) #industry. There, they are used in industrial applications, maintenance, medicine, learning or #work safety. #AR #VR #AugmentedRealitiy #VirtualReality #automation #security #safety

Read More

The Yokogawa Life Innovation Business is on the move

Yokogawa has long been committed to the sustainability goals formulated by the UN. In this context, the focus is on good health and well-being. Against this background, the aim is to strengthen the Life Science division in a targeted and sustainable manner in the future.
In order to drive this forward in Europe, Dr. Gerd Heimlich, has now joined Yokogawa as a new a new sales and market developer at Yokogawa Germany, has now assumed responsibility for the Life Innovation Business (LIB). He has worked in the medical device industry for the past 14 years. Prior to that, he was a life science researcher in the field of programmed cell death (apoptosis).
After a first visit to Yokogawa’s global LIB headquarters in Kanazawa, Japan, Dr. Heimlich was available for an interview. Among other things, he talked about the future direction of the Life Innovation Business and the changes that the near future will bring.

Read More

Ecosystems – new business models: important for disruption strategies

Industry 4.0 describes a fundamental innovation and transformation process of industrial value creation. The leitmotifs of this change are new forms of management and work in global, digital ecosystems. Industry 4.0 is currently the number one topic of discussion in business and the media. But it is not only the digital revolution in the industrial sector that continues to progress. All other sectors, such as healthcare, are also continuing to develop consistently and drastically. Consequently, the term “Healthcare 4.0” is currently being used by many. We see in the media the emergence of some innovative trends that benefit the healthcare sector and, of course, us as users.

Read More